PARP1 and pancreatitis: For example, olaparib alleviates pancreatitis and inflammatory cytokine production in murine models.[51] Similarly, we showed that the application of the PARP inhibitor PJ34 alleviated oxidative stress‐induced parthanatos and inflammatory responses.